Nvidia and pharmaceutical company Eli Lilly are investing up to $1 billion over five years to establish a co-innovation lab in the San Francisco Bay Area focused on AI-assisted drug discovery. The lab will use Nvidia's BioNeMo platform and newly announced Vera Rubin GPUs to develop foundation models for biology and chemistry.

3m read timeFrom go.theregister.com
Post cover image

Sort: